Resources

Online inquiry

  •  

Contact us

M13 Phage Overview

Background Structure Lifecycle Applications Services & Products FAQs Related Sections

Biology of M13 Bacteriophage

M13 bacteriophage is a filamentous virus that infects Gram-negative bacteria, specifically Escherichia coli (E. coli) strains housing the F plasmid. Discovered in 1963, M13 belongs to the Inoviridae family and is classified as an Ff phage (along with fd and f1), named for its specificity to the F pilus. Unlike lytic phages that burst and kill their host cells, M13 establishes a chronic infection. Progeny virions are continuously assembled and secreted through the bacterial membrane, slowing the host's growth rate but allowing it to survive and continue dividing. This unique non-lytic lifecycle is a cornerstone of its utility in biotechnology, particularly for high-titer phage production.

At Creative Biolabs, we leverage the M13 system to build comprehensive Phage Services for diverse applications spanning drug discovery, vaccine development, synthetic biology, and material science. In addition to M13, we provide resources on other phage systems:

Genome Structure and Capsid Proteins

The M13 virion is a flexible filament approximately 880–900 nm long and 6.5 nm in diameter. The genetic material is a circular single-stranded DNA (ssDNA) molecule of exactly 6407 nucleotides. The genome contains 9 genes that encode 11 distinct proteins, grouped by function: replication (pII, pV, pX), structural assembly (pI, pIV, pXI), and capsid formation.

Fig.1 Schematic diagram of M13 phage structure.Fig.1 M13 phage structure.1

Major Coat Protein (pVIII)

The viral capsid is primarily composed of the pVIII major coat protein (encoded by gene VIII). Approximately 2,700 copies of pVIII form a helical tube around the central ssDNA core. pVIII is a small, amphipathic protein (50 amino acids) with a positively charged C-terminus that interacts electrostatically with the DNA inside the virion. While pVIII can be used for phage display (polyvalent display), the inserted peptide length is limited to 6–8 amino acids to avoid disrupting the capsid structure.

Minor Coat Proteins

The filament ends are capped by minor coat proteins essential for infectivity and stability:

  • Infective End (pIII & pVI): One end contains ~5 copies of pIII (gene III) and pVI (gene VI). pIII is the largest coat protein (406 aa) and mediates infection by binding to the F pilus and TolA receptor. It is the most robust site for displaying large proteins like antibodies (scFv, Fab).
  • Assembly End (pVII & pIX): The opposite rounded end contains ~5 copies of pVII (gene VII) and pIX (gene IX). These small hydrophobic proteins initiate the assembly process and are the first to exit the cell during secretion.

The Non-Lytic Lifecycle

The M13 lifecycle is a sophisticated process occurring in four main stages, taking approximately 10 minutes to produce the first progeny, with secretion rates reaching 1,000 phage/cell in the first hour.

01

Infection

02

Replication

03

Assembly

04

Secretion

Step 1: Attachment. The pIII protein binds to the tip of the F pilus on the male E. coli. This binding triggers the pilus to retract, pulling the phage to the periplasm. pIII then interacts with the host's TolA coreceptor in the inner membrane, facilitating the injection of the viral (+) ssDNA into the cytoplasm.
Step 2: Conversion to RF. Host enzymes convert the (+) ssDNA into a double-stranded Replicative Form (RF) DNA. This RF acts like a plasmid, serving as a template for transcription of viral proteins (pII, pX, pV, etc.). The viral protein pII nicks the RF to initiate rolling circle replication, generating new (+) ssDNA strands.
Step 3: Packaging Preparation. As new (+) ssDNA is synthesized, it is immediately coated by dimers of the single-stranded DNA-binding protein pV (gene V). This forms a linear, rod-like complex in the cytoplasm, preventing the DNA from being converted back to RF dsDNA and targeting it for assembly.
Step 4: Extrusion. The pV-DNA complex moves to the inner membrane, where a channel formed by viral proteins pI, pIV, and pXI (the exit pore) is located. As the DNA passes through this channel, pV is stripped off and replaced by the capsid proteins (pVIII, pIII, etc.) which are embedded in the membrane. The mature virion is extruded into the medium without lysing the cell.

Applications: Phage Display & Nanotechnology

Phage Display Technology

M13 is the gold standard for phage display. By fusing foreign DNA sequences to gene III or gene VIII, researchers create a physical link between genotype and phenotype. This allows for:

  • Antibody Discovery: Construction of massive libraries (1010 variants) of scFv or Fab fragments to isolate high-affinity binders for therapeutic targets.
  • Epitope Mapping: Displaying peptide libraries to identify antigen-antibody binding sites.
  • Phagemid Vectors: Most systems use phagemids (plasmids with M13 origin) + Helper Phage (M13KO7) to package the library. This system allows the display of large proteins that might otherwise interfere with phage infectivity if encoded on the whole phage genome.

M13 in Nanotechnology

Beyond biology, the physical properties of M13 (high aspect ratio, monodispersity, and modifiable surface) make it a versatile scaffold for nanotechnology:

  • Nanowires & Batteries: M13 can be engineered to nucleate inorganic materials. Researchers have used M13 templates to grow cobalt oxide and gold nanowires for high-performance lithium-ion battery electrodes.
  • Biosensors: The massive array of pVIII proteins can be chemically modified or genetically engineered to bind specific analytes, allowing M13 to serve as a sensitive element in colorimetric or electrochemical sensors.
  • Drug Delivery: The phage can be targeted to specific cells (via pIII modification) while carrying drug payloads conjugated to the pVIII coat, offering a vehicle for targeted therapy.

Services & M13 Products

We provide a complete portfolio of services and products centered around the M13 platform.

M13 Phage Production

High-titer production and purification of M13 bacteriophage for research and industrial applications. We ensure high viability and purity.

Learn more about Phage M13 Production »

Helper Phage Production

Supply of essential helper phages including M13KO7 and VCSM13 for efficient phagemid rescue and library screening.

M13KO7 Helper Phage Production »

M13 Phage Display System Construction

Custom construction of M13-based display systems, optimizing linker sequences and fusion sites on pIII or pVIII.

View M13 Phage Display System Construction Services »

Antibody Library Construction

Generation of large-scale Fab or scFv libraries using M13 phagemid vectors for the isolation of high-affinity binders.

View Phage Display Antibody Library Construction Service »

M13 Related Products

We offer high-quality reagents to support your M13 research:

Category Product Type Applications
M13 Antibodies Anti-M13 pVIII (Clone UN-rj4), Anti-M13 pIII (Clone NN16) ELISA, Western Blot, Flow Cytometry
DNA Detection Anti-ssDNA / Anti-dsDNA Antibodies Detection of RF or viral ssDNA
ELISA Kits ssDNA/dsDNA ELISA Kits, M13 Titration Kits Quantitative analysis of phage titer

Request a Quote

FAQs

Q: What is the difference between M13 phage and M13KO7 helper phage?

A: Wild-type M13 is a complete virus that can replicate and package its own DNA. M13KO7 is a helper phage used in phagemid display systems. It contains a mutation in the origin of replication and a kanamycin resistance gene. It provides the necessary viral proteins to package a phagemid vector (which encodes the antibody library) into viral particles, rather than packaging its own genome.

Q: Why is M13 used for phage display instead of lytic phages?

A: M13 has a non-lytic lifecycle, meaning infected cells continue to grow and secrete phage particles into the culture medium. This allows for high-throughput screening and easy harvesting of phage clones without destroying the bacterial host. Additionally, the filamentous structure can accommodate DNA insertions of varying lengths within limits.

Q: Can M13 display large proteins?

A: Yes, M13 pIII protein can display large proteins such as scFv and Fab antibody fragments. However, large fusions to the major coat protein pVIII are generally limited to short peptides (6-8 amino acids) due to steric hindrance that can disrupt capsid assembly.

Q: What is the stability of M13 bacteriophage?

A: M13 is exceptionally stable. It can withstand temperatures up to 80°C, extreme pH levels, and exposure to various organic solvents. This robustness makes it an ideal candidate for nanotechnology applications and long-term storage.

Q: How do I store M13 phage stocks?

A: Phage stocks can be stored at 4°C for short periods (weeks to months). For long-term storage, mix the phage supernatant with glycerol to a final concentration of 15-50% and store at -80°C.

Q: Is M13 phage hazardous to humans?

A: No. M13 is a bacteriophage that specifically infects E. coli bacteria. It does not infect human, animal, or plant cells. It is generally classified as a Biosafety Level 1 (BSL-1) agent.

Q: What host strains are required for M13 infection?

A: M13 requires the bacterial F pilus for infection. Therefore, only F+ E. coli strains (containing the F plasmid or F' episome), such as XL1-Blue, TG1, or JM109, can be infected. It cannot infect F- strains.

Q: How can I concentrate M13 phage particles from the culture?

A: The standard method is precipitation using Polyethylene Glycol (PEG) and Sodium Chloride (NaCl). Adding PEG/NaCl to the culture supernatant and incubating on ice causes the phage particles to aggregate, which can then be pelleted by centrifugation.

Q: Does M13 phage form clear plaques?

A: No, M13 does not lyse (burst) the bacterial cells. Instead, it slows down the growth of infected cells. This results in "turbid" plaques—zones of reduced bacterial growth rather than clear zones of cell death seen with lytic phages.

Reference:

  1. Løset, Geir Åge, et al. "Development of Antibody-Array-Based Multiplexed Immunoassays for Detection of Food-Borne Pathogens." PLoS ONE 6(2): e17433. Distributed under Open Access license CC BY 4.0. https://doi.org/10.1371/journal.pone.0017433.
×
Online Inquiry

Please kindly note that our services can only be used to support research purposes (Not for clinical use).

Biophage Technology

Creative Biolabs is a globally recognized phage company. Creative Biolabs is committed to providing researchers with the most reliable service and the most competitive price.

Contact Us
  • Global Locations
Privacy Policy | Cookie Policy | Copyright © 2026 Creative Biolabs. All rights reserved.